Clinical Evidence: What The Research Shows For Each Treatment
Does Wegovy Work The Same As Mounjaro? Understanding The Key Differences
The question "does Wegovy work the same as Mounjaro" reflects the growing interest in prescription weight management options across the UK. While both are injectable treatments designed to support weight loss alongside a reduced-calorie diet and increased physical activity, they operate through distinct biological pathways. Wegovy contains semaglutide, which specifically targets GLP-1 receptors to regulate appetite and gastric emptying. Mounjaro, containing tirzepatide, takes a dual-action approach by activating both GLP-1 and GIP receptors, potentially offering different metabolic effects.
Clinical evidence demonstrates that both treatments can support significant weight management when used as part of a comprehensive programme. However, the trials for each medication used different populations, timeframes, and methodologies, making direct comparisons challenging. What remains consistent is that both represent prescription-only medicines requiring proper medical supervision and ongoing support from qualified healthcare professionals.
Wegovy Pricing Structure: Investment In Your Weight Management Journey
Understanding the cost implications when asking "does Wegovy work the same as Mounjaro" involves examining our transparent pricing structure at EverydayMeds. Single Wegovy pens start at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. These prices reflect the final cost after applying discount codes FIRST40 for new customers or DOSE25 for returning patients at checkout.
Our bundle options provide convenience for consistent supply, such as the Intro Duo (0.25mg & 0.5mg) at £169.99 or the Progress Trio (0.5mg, 1mg & 1.7mg) at £369.99. The Ultimate Stability Trio offers three months of maintenance supply with 2.4mg pens for £649.99, ensuring treatment continuity without multiple orders. Each purchase includes next-day cold-chain delivery once prescribed, maintaining the medication's integrity throughout the supply process.
Clinical Evidence: What STEP Trials Revealed About Wegovy Effectiveness
When evaluating whether Wegovy works the same as Mounjaro, examining published clinical evidence provides crucial insights. The landmark STEP 1 trial, published by Wilding et al. in NEJM 2021, demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo. The STEP 3 trial showed even higher results of around 16% when combined with intensive behavioural therapy.
Long-term data from STEP 5 confirmed sustained weight loss of approximately 15.2% at two years, while the recent SELECT trial revealed a 20% reduction in major cardiovascular events. These findings establish Wegovy's clinical profile, though individual results may vary and cannot be directly compared to Mounjaro trials due to different study designs and populations.
How Wegovy Works: The GLP-1 Mechanism Explained
To understand whether Wegovy works the same as Mounjaro, it's essential to grasp how Wegovy functions in the body. As a GLP-1 receptor agonist, Wegovy mimics a natural hormone called glucagon-like peptide-1, which regulates appetite and food intake through multiple pathways. The medication works on brain appetite centres, particularly in the hypothalamus, to reduce hunger signals and increase feelings of satiety after smaller meals. Additionally, Wegovy slows gastric emptying, meaning food remains in the stomach longer, contributing to prolonged fullness. This mechanism may also help reduce food cravings and the psychological drive to eat, supporting behavioural changes necessary for sustainable weight management. The once-weekly injection schedule helps maintain consistent hormone levels, providing steady appetite regulation throughout the treatment period.
Your Wegovy Journey: From Assessment To Delivery
Accessing Wegovy through EverydayMeds involves a streamlined process designed for UK patients seeking prescription-only weight management support. The journey begins with our 3-minute online clinical assessment, where you'll provide medical history, current medications, and weight management goals to help our prescribers evaluate suitability. Following submission, our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring all clinical safety requirements are met before prescribing. Once approved, your Wegovy pen ships via next-day delivery using specialised cold-chain transport to maintain the 2-8°C storage requirements. Our GPhC #9012878 registered pharmacy ensures all medications meet UK standards for safety and quality. Throughout your treatment, our clinical team remains available for ongoing support and dosing guidance as you progress through the escalation schedule.
Storage And Practical Considerations: Wegovy's Unique Advantages
Practical differences emerge when asking "does Wegovy work the same as Mounjaro," particularly regarding storage and handling requirements. Wegovy must be stored in the refrigerator at 2-8°C before first use, but offers a significant convenience advantage with up to 6 weeks of room temperature stability below 30°C once removed from refrigeration. This extended room temperature tolerance makes Wegovy particularly suitable for travel, holidays, or situations where refrigeration isn't immediately available. The FlexTouch pen system provides precise dosing with a user-friendly design that doesn't require mixing or preparation. The mandatory dose escalation schedule starts at 0.25mg for weeks 1-4, gradually increasing to the 2.4mg maintenance dose by week 17, allowing your body to adapt progressively to the medication's effects. This structured approach helps minimise potential gastrointestinal side effects while optimising treatment tolerance and effectiveness.
UK Weight Loss Results: Real-World Evidence Beyond Clinical Trials
Beyond asking "does Wegovy work the same as Mounjaro," UK patients want to understand real-world effectiveness in diverse populations. Post-market surveillance data suggests that clinical trial results translate reasonably well to routine clinical practice, though individual responses vary significantly based on baseline characteristics, adherence to dietary modifications, and concurrent lifestyle interventions. The UK's NICE guidelines (TA875) recommend Wegovy specifically with specialist weight management support, recognising that optimal outcomes require comprehensive care rather than medication alone.
Patient-reported outcomes from UK weight management services indicate that successful Wegovy users typically combine the prescription-only medicine with structured nutritional counselling, regular physical activity, and ongoing behavioural support. This multidisciplinary approach aligns with the medication's licensed indication as an adjunct to, rather than replacement for, lifestyle modifications in achieving sustainable weight management goals.
Making Your Decision: Wegovy Access Through EverydayMeds
If you're still wondering "does Wegovy work the same as Mounjaro," remember that both treatments are available through EverydayMeds, and your prescriber can help determine which option aligns with your individual medical profile and weight management objectives. New customers can use code FIRST40 at checkout, while returning patients apply code DOSE25 to access our competitive pricing structure. Our clinical assessment process ensures appropriate prescribing in compliance with MHRA guidelines, while our next-day delivery service gets your prescription-only medicine to you quickly and safely. The EverydayMeds clinical team, operating under GPhC #9012878, provides ongoing support throughout your weight management journey, helping you navigate any questions or concerns that arise during treatment. Start your assessment today at https://everydaymeds.co.uk/collections/wegovy to explore whether Wegovy could support your health goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
